Literature DB >> 21532012

Preventing and managing antimicrobial resistance: imperative for chest physicians.

M C Raviglione, C Lange, G B Migliori.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21532012     DOI： 10.1183/09031936.00003111

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  4 in total

Review 1.  Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones.

Authors:  Giovanni Battista Migliori; Miranda W Langendam; Lia D'Ambrosio; Rosella Centis; Francesco Blasi; Emma Huitric; Davide Manissero; Marieke J van der Werf
Journal:  Eur Respir J       Date:  2012-05-31       Impact factor: 16.671

2.  Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis.

Authors:  Vija Skripconoka; Manfred Danilovits; Lea Pehme; Tarmo Tomson; Girts Skenders; Tiina Kummik; Andra Cirule; Vaira Leimane; Anu Kurve; Klavdia Levina; Lawrence J Geiter; Davide Manissero; Charles D Wells
Journal:  Eur Respir J       Date:  2012-09-27       Impact factor: 16.671

Review 3.  New anti-tuberculosis drugs and regimens: 2015 update.

Authors:  Lia D'Ambrosio; Rosella Centis; Giovanni Sotgiu; Emanuele Pontali; Antonio Spanevello; Giovanni Battista Migliori
Journal:  ERJ Open Res       Date:  2015-05-06

4.  Practical Approach to Lung Health - Experience from the Republic of Macedonia.

Authors:  Biljana Ilievska-Poposka; Maja Zakoska; Stefan Talevski
Journal:  Open Access Maced J Med Sci       Date:  2018-03-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.